Neobryxol Forte
NDC Package 45984-0002-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Neobryxol Forte is indication: Maintains the system under the stress of malignancy regardless of location. Marketed by Bryomed Inc., this product is identified by NDC 45984-0002.

Identification & Billing

NDC Package Code
45984-0002-1
Package Description
30 mL in 1 BOTTLE, SPRAY
Product Code
45984-0002
11-Digit Billing Format
45984000201

Clinical Specifications

Proprietary Name
Neobryxol Forte
Dosage Form
-
Usage Information
Indication: Maintains the system under the stress of malignancy regardless of location. Targets tissues that tend to be more susceptible to cancer, neuralgias and dropsy of extremities, yellowed skin, headache, physical weakness and rheumatic pains.Based on the homeopathic Materia  Medicas.Reference image forte.jpg

Regulatory & Marketing

Labeler Name
Bryomed Inc.
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
04-04-2012
Listing Expiration
12-31-2018
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 45984-0002-1 identifies a specific commercial package of 30 ml in 1 bottle, spray of Neobryxol Forte, labeled by Bryomed Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Bryomed Inc. on April 04, 2012. The current certification is valid through December 31, 2018.

How is this Bryomed Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 45984000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
45984-0002-1
11-Digit CMS (5-4-2)
45984-0002-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.